Prosecution Insights
Last updated: October 02, 2026

Wake Forest University Health Sciences

Technology area: Biotechnology & Pharmaceuticals

14 pending office actions • 12 art units • 13 examiners • 0 of 14 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days

Analysis

Wake Forest University Health Sciences manages 15 pending office actions in the Biotechnology & Pharmaceuticals technology area. This portfolio is distributed, involving 14 distinct examiners and 12 distinct art units. Such a spread suggests that the university's research covers an array of biological and pharmaceutical sub-specialties, requiring engagement with many different technical divisions at the patent office.

The busiest examiner for this portfolio is MOLOYE, TITILAYO, who is currently managing 2 pending office actions. This concentration of cases under the busiest examiner, compared to the total of 15 pending office actions, highlights the variety of the portfolio. With 12 distinct art units involved, the university must manage a prosecution strategy that accounts for the varying standards across this portion of the biotechnology and pharmaceutical sectors. The presence of 14 distinct examiners further emphasizes the need for a multifaceted approach to these 15 pending office actions.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

14
Total Pending OAs
9
Non-Final OAs
4
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (1)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

10
Hard (71%)
4
Medium (29%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other5 (36%)
§103 only3 (21%)
Double-patenting + other1 (7%)
Multi-statute (no §101)5 (36%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

9
Life Sciences
64% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
7% of docket
2
Mechanical / Eng
14% of docket
2
Business / Other
14% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

140 h
Manual time on pending OAs
28 h
Time saved (low, 20%)
49 h
Time saved (mid, 35%)
1.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MOLOYE, TITILAYO 2 62.5% +47.9%
COFFA, SERGIO 1 61.1% +32.5%
WESTON, ALYSSA G 1 59.8% +50.9%
CANDELARIA, JULIANA IRENE 1 0.0% +0.0%
DONOHUE, SEAN R 1 41.4% +21.0%
LANDAU, SHARMILA GOLLAMUDI 1 11.1% +4.6%
GU, QINHUA 1 75.9% +27.8%
MILLER, SERENITY A 1 68.0% +36.9%
POLIAKOVA-GEORGAN, EKATERINA 1 64.0% +18.0%
XIAO, YAN 1 67.3% +52.7%

Hard Cases (10)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18603721 COMPOUNDS AND COMPOSITIONS USEFUL AS RADIOTRACERS FOR IMAGING OF REACTIVE OXIDATIVE SPECIES DONOHUE, SEAN R 28d overdue
18731629 ORGANOIDS RELATED TO IMMUNOTHERAPY AND METHODS OF PREPARING AND USING THE SAME WESTON, ALYSSA G —
18645616 Rotator Cuff Therapy Using Muscle Fiber Fragments CANDELARIA, JULIANA IRENE —
18544936 COMPOSITIONS, CELL CONSTRUCTS, AND METHODS OF MAKING AND USING THE SAME MOLOYE, TITILAYO —
18538015 SPONTANEOUSLY BEATING CARDIAC ORGANOID CONSTRUCTS AND INTEGRATED BODY-ON-CHIP APPARATUS CONTAINING THE SAME LANDAU, SHARMILA GOLLAMUDI —
18287491 MINIMALLY INVASIVE APPENDECTOMY DEVICE AND METHOD MILLER, SERENITY A —
18037708 VECTORS, SYSTEMS AND METHODS FOR EUKARYOTIC GENE EDITING POLIAKOVA-GEORGAN, EKATERINA —
18157759 CALIBRATION OF SOLID-STATE SENSORS DO, AN H —

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18603721 COMPOUNDS AND COMPOSITIONS USEFUL AS RADIOTRACERS FOR IMAGING OF REACTIVE OXIDATIVE SPECIES DONOHUE, SEAN R 28d overdue
18316672 EPHA3 AND MULTI-VALENT TARGETING OF TUMORS XIAO, YAN 21d
18289875 GENE THERAPY FOR DENT DISEASE GU, QINHUA 60d
18794181 AMNIOTIC MEMBRANE POWDER AND ITS USE IN WOUND HEALING AND TISSUE ENGINEERING CONSTRUCTS COFFA, SERGIO —
18731629 ORGANOIDS RELATED TO IMMUNOTHERAPY AND METHODS OF PREPARING AND USING THE SAME WESTON, ALYSSA G —
18544936 COMPOSITIONS, CELL CONSTRUCTS, AND METHODS OF MAKING AND USING THE SAME MOLOYE, TITILAYO —
18287491 MINIMALLY INVASIVE APPENDECTOMY DEVICE AND METHOD MILLER, SERENITY A —
18037708 VECTORS, SYSTEMS AND METHODS FOR EUKARYOTIC GENE EDITING POLIAKOVA-GEORGAN, EKATERINA —

Top Art Units

Art UnitApps
1658 1
1634 1
1618 1
1653 1
1633 1
3771 1
1637 1
1642 1
2853 1
1632 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18794181 AMNIOTIC MEMBRANE POWDER AND ITS USE IN WOUND HEALING AND TISSUE ENGINEERING CONSTRUCTS COFFA, SERGIO 1658 §103DP Non-Final OA — Pending Aug 05, 2024
18731629 ORGANOIDS RELATED TO IMMUNOTHERAPY AND METHODS OF PREPARING AND USING THE SAME WESTON, ALYSSA G — §101§102§103§112DP Non-Final OA — Pending Jun 03, 2024
18645616 Rotator Cuff Therapy Using Muscle Fiber Fragments CANDELARIA, JULIANA IRENE 1634 §102§103§112 Non-Final OA — Pending Apr 25, 2024
18603721 COMPOUNDS AND COMPOSITIONS USEFUL AS RADIOTRACERS FOR IMAGING OF REACTIVE OXIDATIVE SPECIES DONOHUE, SEAN R 1618 §103§112 Final Rejection 28d overdue Pending Mar 13, 2024
18544936 COMPOSITIONS, CELL CONSTRUCTS, AND METHODS OF MAKING AND USING THE SAME MOLOYE, TITILAYO — §103§112 Non-Final OA — Pending Dec 19, 2023
18538015 SPONTANEOUSLY BEATING CARDIAC ORGANOID CONSTRUCTS AND INTEGRATED BODY-ON-CHIP APPARATUS CONTAINING THE SAME LANDAU, SHARMILA GOLLAMUDI 1653 §103§112 Non-Final OA — Pending Dec 13, 2023
18289875 GENE THERAPY FOR DENT DISEASE GU, QINHUA 1633 §103 Final Rejection 60d Pending Nov 07, 2023
18287491 MINIMALLY INVASIVE APPENDECTOMY DEVICE AND METHOD MILLER, SERENITY A 3771 §102§103§112 Non-Final OA — Pending Oct 19, 2023
18037708 VECTORS, SYSTEMS AND METHODS FOR EUKARYOTIC GENE EDITING POLIAKOVA-GEORGAN, EKATERINA 1637 §101§103DP Non-Final OA — Pending May 18, 2023
18316672 EPHA3 AND MULTI-VALENT TARGETING OF TUMORS XIAO, YAN 1642 §103 Final Rejection 21d Pending May 12, 2023
18157759 CALIBRATION OF SOLID-STATE SENSORS DO, AN H 2853 §101§102 Non-Final OA — Pending Jan 20, 2023
17643441 BLOOD BRAIN BARRIER MODEL AND METHODS OF MAKING AND USING THE SAME MOLOYE, TITILAYO 1632 §101§103 Non-Final OA — Pending Dec 09, 2021
17048879 A MEDICAL DEVICE FOR DEPLOYING A CATHETER THAT CAN BE OPERATED WITH A SINGLE HAND, AND A METHOD SMALE, AVERY E 3783 §103 Final Rejection 24d overdue Pending Oct 19, 2020
16921287 METHODS OF PREDICTING PREDISPOSITION TO OR RISK OF KIDNEY DISEASE SITTON, JEHANNE SOUAYA 1682 §101§112DP Non-Final OA — Pending Jul 06, 2020

Managing Wake Forest University Health Sciences's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month